Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Si-Bone (SIBN) Cash & Equivalents (2017 - 2025)

Si-Bone (SIBN) has 9 years of Cash & Equivalents data on record, last reported at $42.2 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 20.87% year-over-year to $42.2 million; the TTM value through Dec 2025 reached $42.2 million, up 20.87%, while the annual FY2025 figure was $42.2 million, 20.87% up from the prior year.
  • Cash & Equivalents reached $42.2 million in Q4 2025 per SIBN's latest filing, up from $21.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $110.8 million in Q2 2023 and bottomed at $8.0 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $36.6 million, with a median of $31.1 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: crashed 87.38% in 2022, then soared 355.67% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $63.4 million in 2021, then tumbled by 87.38% to $8.0 million in 2022, then soared by 315.78% to $33.3 million in 2023, then rose by 5.04% to $34.9 million in 2024, then rose by 20.87% to $42.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $42.2 million in Q4 2025, $21.4 million in Q3 2025, and $27.8 million in Q2 2025.